IHL : Incannex engages Procaps to develop and manufacture IHL-675A soft-gel capsules in preparation for clinical trials Jul 16, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
Positive pre-IND meeting with US FDA and ethics approval to commence Phase 2a Psi-GAD clinical trial: psilocybin-assisted psychotherapy for Generalised Anxiety Disorder Oct 28, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
NYR In Vivo Trial Results Show Further Positive Results Aug 16, 2021 | ASX News, Nyrada Inc (ASX:NYR)